Table 2 Proportion of osteopenia or osteoporosis.

From: Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study

Time

Diagnosis

CAB group (N = 234)

GnRH group (N = 70)

p-value

n

(%)

n

(%)

Baseline

n

234

70

 

Normal (T ≥ −1.0)

120

(51.28)

35

(50.00)

0.9427 †

Osteopenia (−2.5 < T < −1.0)

92

(39.32)

29

(41.43)

 

Osteoporosis (T ≤ −2.5)

22

(9.40)

6

(8.57)

 

12 month

n

186

55

 

Normal (T ≥ −1.0)

81

(43.55)

20

(36.36)

0.3688 †

Osteopenia (−2.5 < T < −1.0)

81

(43.55)

24

(43.64)

 

Osteoporosis (T ≤ −2.5)

24

(12.90)

11

(20.00)

 
  1. †Pearson’s chi-square test.
Back to article page